No Chart Data Available
No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹110.2Prev. Close
₹105Turnover(Lac.)
₹6.45Day's High
₹110.25Day's Low
₹102.552 Week's High
₹152.3552 Week's Low
₹88.05Book Value
₹47.99Face Value
₹10Mkt Cap (₹ Cr.)
118.84P/E
24.95EPS
4.31Divi. Yield
030 Aug 2025
12:00 AM
AGM
Announcement Date: 30 Aug, 2025
7 Nov 2025
12:00 AM
Board Meeting
Agenda : Audited Result
28 May 2025
12:00 AM
Dividend
Dividend Amount: 0.1
Record Date: 19 Sep, 2025
No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 11.05 | 11.05 | 17.52 | 2.3 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 41.98 | 37.22 | 3.47 | 4.8 |
Net Worth | 53.03 | 48.27 | 20.99 | 7.1 |
Minority Interest |
No Record Found
No Record Found
No Record Found
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 96.99 | 103.83 | 77.48 | 48.84 | 28.6 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 96.99 | 103.83 | 77.48 | 48.84 | 28.6 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 3.9 | 0.49 | 0.93 | 0.11 | 0.22 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,610.6 | 82.66 | 3,86,328.92 | 564.22 | 0.99 | 4,511.27 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,188 | 65.5 | 1,64,674.14 | 696 | 0.48 | 2,660 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,958.7 | 62.73 | 1,33,890.71 | 597 | 0.15 | 2,707 | 249.82 |
Cipla Ltd CIPLA | 1,328.4 | 23.42 | 1,07,292.21 | 616.88 | 1.2 | 4,256.93 | 411.56 |
Dr Reddys Laboratories Ltd DRREDDY | 1,222.5 | 22.02 | 1,02,183.79 | 90.6 | 0.65 | 4,266.4 | 377.56 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Sharadkumar Dashrathbhai Patel
Whole-time Director
Dineshkumar Babulal Gelot
Executive Director
Vishalkumar Devrajbhai Patel
Executive Director
Chetankumar Bachubhai Patel
Independent Non Exe. Director
Bhavinkumar Prafulbhai Joshi
Independent Non Exe. Director
Ketankumar Arvindbhai Modi
Independent Non Exe. Director
Dimpal Dhebarbhai Pate
Company Sec. & Compli. Officer
Niyati Dipesh Parikh
Plot No PF-21 Nr ACME Pharma,
Opp Teva Pharma Sanand GIDC-II,
Gujarat - 382110
Tel: 91-90819 93300
Website: http://www.sotacpharma.com
Email: compliance@sotacpharma.com
Karvy Selenium Tow-B,
31&32 Financial Dist, Nanakramguda,
Hyderabad-500032
Tel: 91-40-67162222
Website: www.kfintech.com
Email: einward.ris@karvy.com
Summary
Sotac Pharmaceuticals Limited was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name of M/s Sotac Pharmaceuticals, pursuant to a Deed of Partnership da...
Read More
Reports by Sotac Pharmaceuticals Ltd
What is the Sotac Pharmaceuticals Ltd share price today?
What is the Market Cap of Sotac Pharmaceuticals Ltd?
What is the PE and PB ratio of Sotac Pharmaceuticals Ltd?
What is the 52 Week High and Low of Sotac Pharmaceuticals Ltd?
What is the CAGR of Sotac Pharmaceuticals Ltd?
What is the shareholding pattern of Sotac Pharmaceuticals Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
